Andy D'Silva
Equibles does not estimate personal net worth.
Get an email with a short summary when OptimizeRx Corp publishes a filing, an earnings call transcript or a press release.
Get OPRX alertsAbout Andy D'Silva
Andy D'Silva is recorded as CFO at OptimizeRx Corp (OPRX) since January 1, 2027. OptimizeRx Corp reported in an 8-K filed August 12, 2026 that Andy D'Silva was appointed Chief Financial Officer, effective January 1, 2027. OptimizeRx Corp reported in an 8-K filed August 19, 2025 that Andy D'Silva was appointed Chief Business Officer. OptimizeRx Corp is classified in the Health Information Services industry within the Healthcare sector. Other leadership on record at OptimizeRx Corp includes Stephen Silvestro (CEO and Board Member), William Febbo (CEO and Board Member), William J. Febbo (CEO and Board Member) and 7 others.
“The Company's Board of Directors has appointed Andy D'Silva to succeed Ed Stelmakh as Chief Financial Officer, effective January 1, 2027.”
“Andy D'Silva has been promoted to Chief Business Officer (CBO) from the role of SVP, Corporate Finance.”
Affiliation history
-
Current
2027-01-01–present
-
OptimizeRx Corp (OPRX)
SEC 8-K
Current2025-08-19–present
Company network
Leadership on record at OptimizeRx Corp
- Stephen Silvestro CEO, Board Member
- William Febbo CEO, Board Member
- William J. Febbo CEO, Board Member
- Lynn O'Connor Vos Chairman, Board Member
- Andrew D'Silva CFO
- Andrew D’Silva CFO
- Douglas P. Baker CFO
- Brendan Merrell COO
- Edward Stelmakh COO
- Todd Inman CTO